TNFA

TNF Pharmaceuticals (TNFA)

TNF Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TNFA

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/19	23 : 15	Business Wire	TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/12/10	22 : 20	AllPennyStocks.com	Premarket Action Is Heating Up For This Biotech	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/12/09	23 : 00	Business Wire	TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/11/26	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/11/15	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/11/15	04 : 24	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/11/02	05 : 31	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/11/02	05 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/10/05	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/10/02	22 : 10	Business Wire	TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/09/24	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/21	22 : 00	Business Wire	TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/19	19 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/15	05 : 33	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/15	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/13	06 : 10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/08/09	06 : 13	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/07/27	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/07/27	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNFA	TNF Pharmaceuticals Inc
2024/07/24	22 : 05	Business Wire	TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today	NASDAQ:TNFA	TNF Pharmaceuticals Inc